Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $21.52B | $21.18B | +1.57% |
Cost of Revenue | $4.61B | $4.67B | -1.28% |
Operating Income | $8.04B | $-790M | +1117.47% |
Net Income | $6.33B | $-1.3B | +585.57% |
EPS (Basic) | $5.08 | $-1.04 | +588.46% |
EPS (Diluted) | $5.04 | $-1.04 | +584.62% |
SG&A Expense | $3.98B | $4.18B | -4.88% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $58.53B | $54.52B | +7.35% |
Current Assets | $17.87B | $14.78B | +20.94% |
Current Liabilities | $12.3B | $11.72B | +4.89% |
Stockholders' Equity | $21.54B | $18.48B | +16.59% |
Long-Term Debt | $24.94B | $23.25B | +7.28% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $6.69B | $7.85B | -14.78% |
Investing Cash Flow | $-2.96B | $-3.22B | +8.25% |
Financing Cash Flow | $-6.48B | $-5.69B | -13.86% |
Dividends Paid | $3.01B | $2.94B | +2.17% |
Share Buybacks | $1.69B | $800M | +111.50% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | 37.4% | -3.7% | +41.08% |
Net Margin | 29.4% | — | — |
ROE | 29.4% | — | — |
ROA | 10.8% | — | — |
Current Ratio | $1.453 | — | — |
Other companies in Biotechnology